Feb 19, 2026 First Group Leaders announced for new dedicated Parkinson's Research Centre In 2025, the UK DRI partnered with Parkinson’s UK to launch a new £10m research... Learn more First Group Leaders announced for new dedicated Parkinson's Research Centre
Jan 01, 2024 Why partner with the UK DRI? The UK DRI is central to a rich and connected dementia research ecosystem, and we... Learn more Why partner with the UK DRI?
Jan 01, 2024 Why join the UK DRI? By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists... Learn more Why join the UK DRI?
Search for keywords Condition ConditionAlzheimer's diseaseFrontotemporal dementiaHuntington's diseaseLewy body dementiaMild cognitive impairmentMotor neuron disease/ALSOther conditionsParkinson's diseaseVascular dementia Techniques TechniquesAdvanced microscopy & imagingAdvanced spectroscopyBioinformaticsBiophysical techniquesCRISPRDrug screeningElectrophysiologyEpigenomicsExperimental medicineFlow cytometryFluid biomarkersGenomicsHuman brain imagingLipidomicsMass spec-based proteomicsMetabolomicsMouse behaviourMouse in vivo imagingNext generation sequencingNon-mammalian animal modelsOptogeneticsRobotics & environmental sensingSingle cell / nucleus transcriptomicsSoftware developmentSpatial transcriptomicsStatistical modellingStem cells / iPSCsStructural biologyTranscranial brain stimulationViral-mediated expression Topic TopicAgeingBiomarkers & diagnosticsCare & Home technologyCell biology of neurons & gliaGeneticsImmune systemLifestyle & environmentMolecular mechanismsSleep & Circadian rhythmsSynapse & CircuitryTreatments & InterventionsVascular system Ms. Rahema Mohammad PhD student Learn more Ms. Rahema Mohammad Dr Axel Montagne Group Leader UK DRI at Edinburgh Exploring the link between cerebrovascular and inflamm-ageing to neurodegeneration and dementia Learn more Dr Axel Montagne Kylie-Ann Montgomery PhD Student Learn more Kylie-Ann Montgomery Dr Jimena Monzon Sandoval Bioinformatician Aiming to better understand molecular mechanisms driving altered gene expression and pathway dysregulation through transcriptomic analyses in disease models, aiding the identification of therapeutic targets for neurodegenerative diseases. Learn more Dr Jimena Monzon Sandoval Jay Moore PhD Student Mapping cell-type-specific vulnerability by integrating large-scale genomic and neuropathological data. Learn more Jay Moore Amelia Moore Research Assistant Learn more Amelia Moore Dr Pierre Mora Postdoctoral Researcher Learn more Dr Pierre Mora Dr Laura Morcom Postdoctoral Researcher Learn more Dr Laura Morcom Prof Paul Morgan Interim Centre Director UK DRI at Cardiff Investigating exactly how key immune proteins contribute to Alzheimer's disease development Learn more Prof Paul Morgan Monica Morim Honorary Clinical Researcher Learn more Monica Morim Dr Mizuki Morisaki Postdoctoral Researcher Learn more Dr Mizuki Morisaki Paul Morrill Research Technician Learn more Paul Morrill Pagination First page First Previous page ‹ … Page 59 Page 60 Current page 61 Page 62 Page 63 … Next page › Last page Last
Dr Axel Montagne Group Leader UK DRI at Edinburgh Exploring the link between cerebrovascular and inflamm-ageing to neurodegeneration and dementia Learn more Dr Axel Montagne
Dr Jimena Monzon Sandoval Bioinformatician Aiming to better understand molecular mechanisms driving altered gene expression and pathway dysregulation through transcriptomic analyses in disease models, aiding the identification of therapeutic targets for neurodegenerative diseases. Learn more Dr Jimena Monzon Sandoval
Jay Moore PhD Student Mapping cell-type-specific vulnerability by integrating large-scale genomic and neuropathological data. Learn more Jay Moore
Prof Paul Morgan Interim Centre Director UK DRI at Cardiff Investigating exactly how key immune proteins contribute to Alzheimer's disease development Learn more Prof Paul Morgan
